Proper blood vessel formation is essential in health and is often dysregulated in ischaemic diseases. Therefore, regulatory mechanisms that control angiogenesis and arteriogenesis are required to improve treatment of ischaemic diseases. The aim of this study was to investigate the role of homeobox transcription factor HoxB5 overexpression during revascularization in ischaemic disease.
Introduction
Ischaemic vascular diseases are still one of the leading causes of death worldwide. 1 However, occlusion of a major arterial blood vessel may induce stimulation and growth of pre-existent collateral vessels to circumvent the reduction of blood flow-a process termed arteriogenesis. A key trigger for the initiation of arteriogenesis is fluid shear-stress that occurs after arterial occlusion. 2, 3 In endothelial cells (ECs), shear-stress increases the production of nitric oxide (NO) which in turn triggers arteriogenesis and angiogenesis. 4,5 -6 A second important stimulus for arteriogenesis in the adult is sterile inflammation. 7, 8 Various growth factors, cytokines, and chemokines as well as bone marrow cells, smooth muscle cells (SMCs), and ECs are involved in the process of arteriogenesis. 9 One of the best characterized molecules in inflammation and a well-known potent inducer of arteriogenesis is monocyte chemoattractant protein-1 (MCP-1), which is produced by SMCs after activation of the endothelium. 4, 5 Consequently, monocytes/ macrophages are attracted by MCP-1, adhere to the vessel wall, accumulate perivascularly, and produce a cocktail of growth factors and cytokines to stimulate collateral growth. 5 Moreover, previous studies in a rabbit hind-limb ischaemia model have shown that administration of MCP-1 accelerated formation of collateral vessels. 10, 11 Homeobox (Hox) genes comprise a family of evolutionary highly conserved transcription factors that are characterized by a unique 60 amino acid DNA-binding homeodomain. 12 Originally, Hox genes were discovered to be essential for anterior-posterior axis pattern formation in Drosophila melanogaster development. 13 In general, Hox transcription factors play a key role in cell and organ differentiation during embryonic development. 14, 15 Accordingly, they are important for the differentiation of mesoderm-derived precursor cells into ECs and regulate EC maturation during vascular development. 16, 17 Several Hox genes from the paralogous group 3 (e.g. HoxA3) increase angiogenic function such as proliferation, migration, adhesion, and sprouting of ECs. 18 -20 Other Hox family group members such as HoxA9 have also been shown to regulate angiogenesis. 21 HoxA9 transactivates transcription of E-selectin, which is an endothelial mediator of initial adhesion of leucocytes to the endothelium during inflammation. 22 -24 Previously, we identified HoxB5 to bind to the cis-acting element in the first intron of the vascular endothelial growth factor receptor-2 (VEGFR-2), which is the earliest marker of endothelial precursor cells. Consistently, HoxB5 overexpression in embryonic stem cells resulted in increased numbers of endothelial precursor cells. 16 In recent studies, we have shown that HoxB5 induced EC sprouting in vitro and, furthermore, had a positive effect on intussusceptive angiogenesis in the chick chorioallantoic membrane assay. This effect was indirectly regulated by up-regulation of angiopoietin-2. 25 Here, we investigated the effect of HoxB5 overexpression during adaptive arteriogenesis and angiogenesis in a mouse model of vascular occlusion. In the present work, we show that HoxB5 has stimulating effects on vascular remodelling by up-regulation of inflammatory molecules such as MCP-1.
Methods

Plasmids, antibodies, and reagents
Monoclonal anti-human HoxB5 antibody (ab58625) from Abcam, polyclonal anti-human Endothelin-1 (ET-1; sc-21625) from Santa Cruz Biotechnology, polyclonal anti-human MCP-1 (#2027) from Cell Signaling, monoclonal anti-MCP-1 (M 2420) from Sigma, polyclonal anti-human eNOS antibody (610296) from BD Biosciences, and monoclonal anti-human E-selectin (BBA16) from R&D systems were used for western blotting. Recombinant human MCP-1 and VEGF-165 proteins were purchased from R&D systems. The human pcDNA3-HoxB5 and empty control (pcDNA3) expression plasmid were cloned as previously published. 16 The bicistronic HoxB5-coding adenoviral particles (AdHoxB5) and the green fluorescent protein (GFP) control adenoviral particles (AdGFP) were cloned and generated by the core facility at UNC Chapel Hill as previously published. 16 
Cell culture
Isolation of human umbilical venous endothelial cells (HUVECs) was performed as previously described. 26 HUVECs were cultured in enhanced EC growth medium (PELOBiotech GmbH, Martinsried, Germany). Human monocytes from buffy coat of healthy donors were isolated using a Biocoll gradient (Biochrom, Berlin, Germany) and purified by the monocyte isolation kit II from Miltenyi Biotec, Bergisch Gladbach, Germany. Cells were cultured in Roswell Park Memorial Institute (RPMI) media supplemented with 10% FBS, 1% non-essential amino acids and 1% penicillin/streptomycin (Life Technologies, Darmstadt, Germany).
Transfection of HUVECs
Cells were cultured to 70% confluence and transfected with pcDNA3-HoxB5 or empty control plasmid using PromoFectin-HUVEC transfection reagent according to the manufacturer's instructions (Promocell, Heidelberg, Germany).
Quantitative real-time PCR
Total RNA was extracted from HUVECs using the Aurum RNA Mini Kit and from mouse muscle tissue using phenol -chloroform isolation (TRIzol, Life Technologies). Thereafter, 1 mg of total RNA was transcribed to cDNA with the iScript cDNA Kit. For quantitative mRNA analysis, real-time PCR was performed using the MyiQ real-time detection system and the MyiQ lightcycler software (all Bio-Rad, Munich, Germany). The housekeeping gene human RNA polymerase II (hRP II) was used for internal normalization. Quantification efficiency was calculated using the DDC T method. 27 Primer sequences are shown in Table 1 .
Western blot
Cells were lysed in radioimmunoprecipitation assay buffer, centrifuged at 10 000 g for 10 min at 48C and the supernatant was collected. Total cellular protein was quantified using the Bradford protein assay (Bio-Rad). Cell supernatant was concentrated using Amicon Ultra- A. Fessner et al.
Units 10 K (Millipore, Schwalbach, Germany). Equal amounts of protein or the concentrated supernatant were loaded on a reducing polyacrylamide gel (12 and 15%), respectively, transferred onto a nitrocellulose membrane and blocked with 3% non-fat dry milk in tris buffered saline with Tween 20. After incubation of primary antibodies overnight at 48C, secondary antibodies from R&D systems conjugated to horseradish peroxidase together with enhanced chemiluminescence reagent (Amersham Bioscience) were used to detect proteins by the use of an imager detection system (Bio-Rad). All western blots were repeated at least three times. Western blot quantification was performed using the Quantity One Analysis Software (Version 4.4, Bio-Rad).
Proteome Profiler TM Human Angiogenesis Antibody Array
Protein expression analysis of pcDNA3-HoxB5 or empty control transfected HUVECs was performed at 48 h post-transfection using the Proteome Profiler TM Human Angiogenesis Antibody Array according to the manufacturer's instructions. The antibody array detects the relative level of 55 angiogenesis-related proteins (R&D Systems, Wiesbaden, Germany).
Cytokine array, ELISA
Protein expression analysis of pcDNA3-HoxB5 or empty control transfected HUVEC supernatants was performed at 48 h post-transfection using the Bio-PlexPro TM -human cytokine, chemokine, and growth factor assay-17Plex antibody panel with the Multiplex Suspension Array Systems (Bio-Rad, Munich, Germany). To determine human interleukin-6 (IL-6) expression, the IL-6 ELISA Kit from BD Biosciences (Heidelberg, Germany) following the manufacturer's instructions was used.
Proliferation assay
Proliferation was performed using a colorimetric BrdU-incorporation ELISA (Roche, Penzberg, Germany). HUVECs were transfected with pcDNA3-HoxB5 or pcDNA3 for 24 h. Thereafter, cells were cultured in fresh medium containing BrdU or recombinant VEGF-165 as a positive control for increased HUVEC proliferation for another 24 h and the ELISA was performed using the manufacturer's instructions.
Migration assay
HUVECs were transfected either with pcDNA3-HoxB5 or with empty control vector. The cell migration assay was performed as previously described. 26 In brief, HUVECs were labelled with 10 mM CFDA-SE (Life Technologies), harvested by centrifugation, suspended in migration medium (RPMI with 0.5% FBS, 0.1% BSA), counted and placed in the upper chamber of a modified Boyden chamber (1 × 10 5 cells per HTS FluoroBlok 24-well chamber; pore size 8 mm; BD Biosciences). The chambers were placed in 24-well culture dishes containing migration medium and recombinant VEGF-165 as a positive control for increased HUVEC migration. After incubation for 4 h at 378C, 5% CO 2 the cells were fixed with 4% paraformaldehyde and migrated cells were counted manually in five random microscopic fields using a fluorescent microscope. For migration of human monocytes, the cells were isolated and 5 × 10 5 cells were placed in the upper chamber of a modified Boyden chamber (pore size 5 mm, BD Biosciences). The chambers were placed into 24-well dishes containing conditioned media from HUVECs transfected with pcDNA3 or pcDNA3-HoxB5 and treated with or without anti-MCP-1 for 30 min or with recombinant MCP-1 as a positive control for increased monocyte migration. After incubation for 2 h at 378C, 5% CO 2 migrated cells were counterstained with trypan blue and counted manually in five random microscopic fields using a haemocytometer and a light microscope.
Hind-limb ischaemia model
Experiments were performed according to the Animals Scientific Procedures Act of 1986, European Commission guidelines and local ethics protocols. Ten-week-old male C57BL/6 mice were purchased from Charles River, Sulzfeld, Germany. Unilateral femoral artery occlusion was performed in C57BL/6N mice under anaesthesia with ketamine (100 mg/ kg) and xylazine (2 mg/kg) by double ligation of the femoral artery proximal to the deep femoral artery and distal femoral artery. Animal numbers are mentioned in the different experimental results. A sham operation was performed on the contralateral leg. After the operation, adenoviral vectors encoding HoxB5 or GFP as a control (2 × 10 8 pfu) were injected in equal amounts into the Mm quadriceps, adductor, and gastronemius of the operated limb (see also Figure 1A ). For analgesia, buprenorphine 0.1 mg/kg was subcutaneously injected every 8 -12 h for 48 h.
Laser Doppler perfusion imaging
The animals were anaesthetized by i.p. injection with ketamine (100 mg/kg) and xylazine (2 mg/kg) and measured with a Periscan PIM II imager (Perimed, Järfälla, Sweden). The readings of three individual measurements per mouse were averaged for each time point. Measurements were performed before and after the operation on Day 0 and on Days 2, 5, 7, 9, 12, and 14. Perfusion ratios of the occluded/non-occluded leg were compared between the treatment groups. After laser Doppler measurement on Day 14 mice were sacrificed by cervical dislocation for tissue isolation.
Immunohistology
For immunohistology, 7 mm frozen tissue sections were fixed in ice-cold acetone at 208C for 5 min. Tissue sections were blocked with 1% non-fat dry milk in PBS for 1 h at room temperature, incubated with primary and secondary antibodies (see Table 1 ) and embedded in Mowiol. All photographs were taken with a Zeiss Axioplan microscope and analysed with Zeiss Axiovision Rel. 4.6. For quantitative evaluation of capillary density, the number of CD31-positive capillaries, CD11b-positive, and F4/80 cells were counted in three random regions of at least eight evenly distributed tissue sections of the Mm quadriceps, adductor, and gastrocnemius at Day 14 after induction of ischaemia.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software, Inc., San Diego, CA, USA). In vitro and in vivo data are presented as means + SEM. Treatment groups were compared by the unpaired Student's t-test and results were considered statistically significant for P , 0.05.
Results
Local overexpression of HoxB5 increases perfusion restoration in the hind-limb ischaemia mouse model
Previously, we have identified HoxB5 as a mediator of blood vessel formation during development. Here, we aimed to prove the hypothesis that HoxB5 might also enhance revascularization in ischaemic diseases of the adult. Therefore, we performed the hind-limb ischaemia mouse model and first of all analysed if HoxB5 expression is altered in the ischaemic limb compared with the sham operated, non-ischaemic limb. At Day 14 post-ligation no significant differences in HoxB5 mRNA expression were detected (Supplementary material online, Figure S1A ). However, we wanted to investigate whether overexpression of HoxB5 might enhance revascularization in ischaemic diseases. Therefore, adenoviral vectors coding for HoxB5 or control (GFP) were injected intramuscularly at ischaemic sites after arterial ligation (see Figure 1A) . First, we confirmed enhanced HoxB5 gene expression at 14 days after adenovirus injection in the respective muscle groups by PCR ( Figure 1C) . Mean tissue levels of HoxB5 in the adductor and gastrocnemius muscle group were 28-fold higher in AdHoxB5-treated mice compared with AdGFP-treated control mice. Time course laser Doppler perfusion imaging (LDPI) measurements over 14 days revealed a significant enhancement of blood vessel perfusion recovery after 9 and 14 days in mice 
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with HoxB5 overexpression compared with the GFP control group (Figure 1B and D) . Consistently, we detected increased capillary density by immunohistochemistry of the distal hind-limb muscle tissues at 14 days after ligation in the HoxB5 group ( Figure 1E and F ) . Thus, HoxB5 enhances revascularization of ischaemic tissues.
Overexpression of HoxB5 increases the expression of pro-angiogenic and inflammatory mediators
To identify the mechanism by which HoxB5 modulates blood vessel formation, we performed a 'proteome-profiler human angiogenesis antibody array' with protein lysates and a 'cytokine array' with the supernatant from HUVECs overexpressing HoxB5 or the corresponding control plasmid (Figure 2A) . Quantification of HoxB5 overexpression in HUVECs is shown in Supplementary material online, Figure S1B and C. For array analysis, we set a cut-off at 1.5-fold up-regulation and thus obtained a list of 26 HoxB5 target proteins (Figure 2A) . Of these candidates, we chose ET-1 and MCP-1 for further analysis due to their strong expression and high impact on pro-angiogenic signalling. 28, 29 We confirmed by western blotting that overexpression of HoxB5 enhanced ET-1 and MCP-1 expression in supernatants of ECs ( Figure 2B and C). In the cytokine array, only IL-6 fulfilled the criteria of .1.5-fold up-regulation (data not shown). We confirmed increased IL-6 expression levels by ELISA and real-time PCR ( Figure 2D and E). Taken together, these results suggest that HoxB5 is involved in inflammation. Therefore, we examined further candidates known to be important in vascular inflammation (data not shown) and detected increased expression of endothelial NO synthase (eNOS) and E-selectin on mRNA and protein levels in HoxB5 transfected cells ( Figure 2F-H) . Altogether, we found that HoxB5 stimulates several key molecules of vascular inflammation and angiogenesis.
Hoxb5 induces a pro-angiogenic EC phenotype and leucocyte migration
To assess the function of HoxB5 in ECs and leucocytes, we performed migration and proliferation assays with HUVECs and investigated leucocyte attraction. Indeed, HUVEC migration was enhanced by HoxB5 as well as control transfected HUVECs by recombinant VEGF that served as a positive control as determined in the modified Boyden chamber system ( Figure 3A) . Furthermore, proliferation of ECs was increased upon HoxB5 overexpression as well as by recombinant VEGF that served as a positive control compared with control conditions ( Figure 3B ). Based on our previous results that HoxB5 increased MCP-1 protein expression ( Figure 2C ), we asked if HoxB5 can induce monocyte attraction in an MCP-1-dependent fashion. As shown in Figure 3C , we used supernatants of HUVECs transfected with HoxB5 or control vector as well as MCP-1 stimulation as a positive control. Indeed, monocyte migration was increased in response to supernatant of HoxB5 transfected ECs compared with control transfected cells. As MCP-1 is highly up-regulated by HoxB5, we aimed to test if MCP-1 plays a functional role in conferring the HoxB5 effects. Therefore, we blocked MCP-1 function in the supernatant using a neutralizing MCP-1 antibody. As expected, neutralization of MCP-1 reduced the migration of monocytes in response to control supernatant; however, blocking MCP-1 in HoxB5-induced supernatant abolished the pro-migratory effect of HoxB5 completely ( Figure 3C ). Taken together, our results demonstrate that HoxB5 induces EC migration and proliferation as well as monocyte migration in a MCP-1-dependent manner.
HoxB5 induces inflammatory mediator up-regulation and leucocyte infiltration in vivo
As we have shown that HoxB5 transfected HUVECs displayed increased MCP-1 and IL-6 expression in vitro ( Figure 2C-E) and that MCP-1 is an important mediator of HoxB5 function in vitro, we aimed to investigate this mechanism in vivo. First, we examined the expression levels of MCP-1 and IL-6 in mouse hind-limb ischaemic tissues. Consistently, we detected increased MCP-1 and IL-6 expression in the muscle tissues of HoxB5-treated mice compared with corresponding controls ( Figure 4A and B) . Next, we investigated by immunohistochemistry using a CD11b antibody if HoxB5 modulates the infiltration of leucocytes into ischaemic tissues. Indeed, leucocyte infiltration was significantly higher in ischaemic tissues of HoxB5-treated mice compared with the corresponding control mice, particularly in the quadriceps and adductor compartments ( Figure 4C and D) . Using the more macrophage-specific F4/80 antibody, we observed enhanced HoxB5 regulates vascular remodelling macrophage invasion also in the gastrocnemius compartment ( Figure 4E and Supplementary material online, Figure S2 ). Taken together, HoxB5 overexpression in vivo under ischaemic conditions enhanced MCP-1 and IL-6 expression. Accordingly, more leucocytes were attracted and vascular remodelling was improved.
Discussion
Previously, we have shown transcription factor HoxB5 to be involved in the differentiation of embryonic stem cells to vascular precursor cells. 16 Furthermore, we have described HoxB5 as an important modifier of angiogenic processes during embryonic development. 25 In the present project, we identified an additional function of HoxB5 as an important modulator of vascular inflammation and vascular remodelling in the mouse hind-limb ischaemia model, which is a well-established model to examine ischaemia-induced neovascularization. 30 We showed that local overexpression of HoxB5 increases blood vessel perfusion restoration in vivo ( Figure 1 ) and stimulates EC proliferation and migration in vitro ( Figure 3) . Interest, HoxB5 overexpression in vitro led to the expression of many pro-inflammatory proteins such as MCP-1, ET-1, and IL-6 ( Figure 2 ). Blocking MCP-1 by a specific antibody abolished HoxB5-induced monocyte attraction in vitro. We confirmed our results by ascertaining increased the expression of MCP-1 and IL-6 in the ischaemic limbs of HoxB5-treated animals compared with control virus-treated mice ( Figure 4A and B).
According to the abundance of these leucocyte attractants, we found higher numbers of CD11b-positive cells in the HoxB5-treated mice ( Figure 4C and D) . HoxB5 expression after viral transduction was not distributed equally between the muscle compartments. This is most likely a result of local virus injections. However, the consequences of HoxB5 overexpression such as MCP-1 and IL-6 expression as well as leucocyte invasion follow the local expression levels ( Figure 4A -C, Supplementary material online, Figure S2 ).
We have shown that HoxB5 overexpression after hind-limb ischaemia increased capillary density ( Figure 1E and F ) . It is established that enhanced capillary density has rather a minor impact on blood perfusion ( Figure 1D ) compared with collateral growth. 2 Consequently, we have analysed the number and area of SMA-positive blood vessels (Supplementary material online, Figure S3 ). In line with our LDPI findings, we observed a trend towards an increased number of SMA-positive vessels upon HoxB5 overexpression. Together with the increased capillary density this might explain the overall enhanced blood perfusion. One of the most prominent driving forces for neovascularization in ischaemic disease is inflammation. 31 In contrast, neovascularization in the embryo occurs without inflammation. 32 It is well known that the process of arteriogenesis, the remodelling of pre-existing collateral blood vessels to functional arteries, is strongly dependent on the accumulation of leucocytes in the perivascular space that release growth factors, cytokines and chemokines to stimulate proliferation and migration of ECs and SMCs. 33, 34 However, inflammation is also an important stimulus for angiogenesis because mediators of inflammation such as VEGF or NO decrease vascular permeability and allow plasma proteins and inflammatory cells to enter the perivascular area. 35 In our work, we
show that local overexpression of HoxB5 increases distal blood flow, capillary density, and regeneration after hind-limb ischaemia ( Figure 1 ) by up-regulation of pro-inflammatory molecules such as MCP-1 and IL-6 ( Figures 2 and 4) . MCP-1 is a well-investigated stimulator of neovascularization in vitro as well as in vivo. 36 Similarly, IL-6 is up-regulated by HoxB5.
It has been shown to be secreted by a variety of vascular cell types, including macrophages, lymphocytes, fibroblasts, ECs, and SMCs. Together with MCP-1 IL-6 enhances monocyte chemotaxis and mediates monocyte activation. 37 Another pro-inflammatory protein that is up-regulated by HoxB5 is E-selectin ( Figure 2F and G) . The E-selectin promoter has numerous potential Hox-binding sites that have been shown to be activated by other Hox family members such as HoxA9. 22 During ischaemic events such as myocardial infarction it is a well-accepted concept that hypoxia induces a sterile inflammation which in turn can cause tissue damage-a process termed reperfusion injury. 38 However, the role of innate immune cells such as monocytes that invade the tissue during reperfusion is controversially discussed. On the one hand innate immune cells may contribute to the progression of tissue damage by increasing inflammation processes but on the other hand they have the ability to induce wound healing, regeneration of ischaemic tissues, and neovascularization. 39 In in vitro experiments ( Figure 3C ), we showed that HoxB5 overexpression increased MCP-1-dependent monocyte attraction as well as we detected in vivo increased levels of MCP1 and increased leucocyte invasion. Although we have formally not proved this mechanism in vivo, it is well known that endogenous MCP-1 plays an important role in the process of neovascularization by recruiting macrophages. 36 Therefore, our data suggest that HoxB5 overexpression induces a set of pro-inflammatory molecules and immune cell invasion that meditate regeneration of ischaemic tissues and neovascularization. A plethora of transcription factors is activated at different sites and times of embryonic development and regulate pattern formation, axis development, and morphogenesis. 40, 41 Of interest, many family members of developmental transcription factors such as Fox, Ets, Rel/ NFkB, and Hox play also an important role in inflammation. 22,42 -44 For example, transgenic mice overexpressing HoxB13 in the murine epidermis displayed persistent inflammation and angiogenesis during skin wound healing. 45 In ECs HoxA9 acts as a pro-inflammatory factor by mediating cytokine induction of E-selectin. 22 Of interest, HoxB7 mRNA is highly expressed in human atherosclerotic plaques compared with normal human arterial media, 46 which again indicates an inflammatory context. 47 Besides inflammation, transcription factors that are known to play a role during embryonic development are often found to be reactivated and overexpressed in cancer. 48 Recently, HoxB5 was reported to be highly expressed in human bladder cancer and thereby increased tumour cell proliferation and migration. 49 Along the same line, we found in our present study that HoxB5 increased EC migration and proliferation ( Figure 3A and B), which are key functions for blood vessel formation. 50, 51 Taken together our findings showed that HoxB5 overexpression induced a pro-inflammatory environment that results in enhanced recovery of blood flow, neovascularization, and thus regeneration.
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